1. Home
  2. ACRE vs VYGR Comparison

ACRE vs VYGR Comparison

Compare ACRE & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRE
  • VYGR
  • Stock Information
  • Founded
  • ACRE 2011
  • VYGR 2013
  • Country
  • ACRE United States
  • VYGR United States
  • Employees
  • ACRE N/A
  • VYGR N/A
  • Industry
  • ACRE Real Estate Investment Trusts
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACRE Real Estate
  • VYGR Health Care
  • Exchange
  • ACRE Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • ACRE 388.6M
  • VYGR 386.1M
  • IPO Year
  • ACRE 2012
  • VYGR 2015
  • Fundamental
  • Price
  • ACRE $7.16
  • VYGR $5.43
  • Analyst Decision
  • ACRE Hold
  • VYGR Strong Buy
  • Analyst Count
  • ACRE 7
  • VYGR 8
  • Target Price
  • ACRE $7.10
  • VYGR $17.00
  • AVG Volume (30 Days)
  • ACRE 442.3K
  • VYGR 583.2K
  • Earning Date
  • ACRE 11-07-2024
  • VYGR 11-12-2024
  • Dividend Yield
  • ACRE 13.95%
  • VYGR N/A
  • EPS Growth
  • ACRE N/A
  • VYGR N/A
  • EPS
  • ACRE N/A
  • VYGR 0.47
  • Revenue
  • ACRE $39,423,000.00
  • VYGR $163,784,000.00
  • Revenue This Year
  • ACRE N/A
  • VYGR N/A
  • Revenue Next Year
  • ACRE $0.48
  • VYGR N/A
  • P/E Ratio
  • ACRE N/A
  • VYGR $11.65
  • Revenue Growth
  • ACRE N/A
  • VYGR 3.40
  • 52 Week Low
  • ACRE $6.25
  • VYGR $5.19
  • 52 Week High
  • ACRE $11.24
  • VYGR $11.72
  • Technical
  • Relative Strength Index (RSI)
  • ACRE 60.42
  • VYGR 34.18
  • Support Level
  • ACRE $6.86
  • VYGR $5.19
  • Resistance Level
  • ACRE $7.15
  • VYGR $5.59
  • Average True Range (ATR)
  • ACRE 0.24
  • VYGR 0.41
  • MACD
  • ACRE 0.05
  • VYGR -0.19
  • Stochastic Oscillator
  • ACRE 81.25
  • VYGR 10.71

About ACRE Ares Commercial Real Estate Corporation

Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: